NEW DELHI: The 10th International Pharmaceutical Exhibition (iPEX), the largest event for the Indian pharmaceutical industry, drew delegates from over 111 countries, showcasing a broad spectrum of pharmaceutical products and innovations.
With participants ranging from nutraceuticals to active pharmaceutical ingredients (APIs), excipients, manufacturing units, retailers, suppliers, and buyers, the exhibition provided a comprehensive platform for industry leaders to present their latest developments.
Among the notable attractions was the Crius Lifesciences booth, which featured an array of flavoured gummies designed to address various health concerns.
Dr Rajani Chinni, Director of Crius Group, introduced these innovative gummies to The New Indian. She emphasised that the gummies are tasty, sugar-free, gelatin-free, and preservative-free, making them suitable for all age groups.
“We are one of the first in India to introduce them. These are especially beneficial for children and the elderly, but anyone can consume them at any time. In this fast-paced life, we often forget to take care of our health, so this is an innovative form.”
Crius Lifesciences not only caters to the Indian market but also exports these nutraceutical products worldwide.
ALSO READ: India pharmacy of world: Union Minister Jitin Prasada at iPEX event – THE NEW INDIAN
Nutraceuticals are one of the fastest-growing sectors in the pharmaceutical market, and Crius Lifesciences offers gummies targeting a range of concerns, including cold and flu, anti-ageing, hair and skin health, heart health, anxiety, and sleep.
In addition to standard gummies, the brand also offers oil-infused variants, such as cod liver oil, flaxseed oil, linseed oil, omega-3, and other fatty acids.
Discussing the efficacy of these products, Dr Chinni stated, “These are as effective as any tablet, capsule, or other generic dosage forms, with the added benefit of better taste and a chewable form.”
The iPEX event, inaugurated by Union Minister of State for Commerce and Industry of India Jitin Prasada, served as a crucial platform for the Indian pharmaceutical industry to demonstrate its innovation and growth, reinforcing India’s reputation as a global leader in pharmaceuticals.